Breathe Well Live Well
Condition: Asthma
Interventions: Drug: SCH 32088 mometasone furoate (MF) metered-dose inhaler; Drug: Placebo metered-dose inhaler BID
Sponsor: Schering-Plough
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: RNS60; Drug: Normal saline (Placebo); Drug: Budesonide (Pulmicort Respules)
Sponsor: Revalesio Corporation
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
|
Healthwatch: Child hospitalizations fall after smoking ban: study
Montreal Gazette But they can also cause or have been associated with other conditions as well, including asthma, emphysema and heart disease among smokers and non-smokers … Smoking Ban Associated with Reduction in Child Hospitalizations |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Placebo Inhalation Powder; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Placebo Oral Capsule; Drug: Prednisolone Oral Capsule
Sponsor: GlaxoSmithKline
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Conditions: Asthma; Allergic Rhinitis
Intervention: Other: Blood donation
Sponsors: Fraunhofer-Institute of Toxicology and Experimental Medicine; Hannover Medical School
Enrolling by invitation – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
|
Child hospitalizations fall after smoking ban: study
Montreal Gazette But they can also cause or have been associated with other conditions as well, including asthma, emphysema and heart disease among smokers and non-smokers … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: FF/GW642444M; Drug: Placebo
Sponsor: GlaxoSmithKline
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Conditions: Asthma; Atherosclerosis; Metabolic Syndrome; Insulin Resistance; Cancer
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting – verified May 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: RO4989991; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: FP 100mcg BID plus GSK2190915 100mg QD (AM); Drug: FP 100mcg BID plus GSK2190915 300mg QD (AM); Drug: FP 100mcg BID plus montelukast 10mg QD (PM); Drug: FP 100mcg BID plus placebo BID; Drug: FP/SAL 100/50mcg BID plus placebo BID
Sponsor: GlaxoSmithKline
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days